Header cover image

Hong Kong (HSI) Biotech Industry Analysis

UpdatedJun 24, 2024
DataAggregated Company Financials
Companies48
  • 7D-2.5%
  • 3M-2.1%
  • 1Y-33.0%
  • YTDn/a

Over the last 7 days, the Biotech industry has dropped 2.5%, driven by a pullback from Akeso of 11%. Meanwhile, Sichuan Kelun-Biotech Biopharmaceutical actually outperformed within the industry, gaining 5.9% in the last week. Overall the industry is down 33% in 12 months. As for the next few years, earnings are expected to grow by 37% per annum.

Industry Valuation and Performance

Has the Hong Kong Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 24 Jun 2024HK$332.5bHK$49.7b-HK$19,449,051,702.5611.4x-17.1x6.7x
Wed, 22 May 2024HK$361.7bHK$49.8b-HK$19,368,355,572.3512.2x-18.7x7.3x
Fri, 19 Apr 2024HK$322.4bHK$49.6b-HK$19,911,350,266.5210.8x-16.2x6.5x
Sun, 17 Mar 2024HK$366.5bHK$47.2b-HK$20,445,921,301.3417.6x-17.9x7.8x
Tue, 13 Feb 2024HK$321.6bHK$46.8b-HK$20,175,287,948.5315.6x-15.9x6.9x
Thu, 11 Jan 2024HK$382.9bHK$46.9b-HK$20,242,897,600.0018x-18.9x8.2x
Sat, 09 Dec 2023HK$399.9bHK$46.9b-HK$20,242,488,582.0017.7x-19.8x8.5x
Mon, 06 Nov 2023HK$413.3bHK$45.2b-HK$18,919,413,159.0012.9x-21.8x9.2x
Wed, 04 Oct 2023HK$400.6bHK$45.0b-HK$19,139,886,127.0013.7x-20.9x8.9x
Fri, 01 Sep 2023HK$390.1bHK$43.5b-HK$16,489,702,446.0015x-23.7x9x
Sun, 30 Jul 2023HK$427.8bHK$35.5b-HK$23,380,251,031.0028x-18.3x12x
Tue, 27 Jun 2023HK$393.4bHK$35.4b-HK$23,246,705,446.0024.9x-16.9x11.1x
Thu, 25 May 2023HK$426.2bHK$36.1b-HK$23,813,255,373.0029.5x-17.9x11.8x
Sat, 22 Apr 2023HK$441.4bHK$37.0b-HK$24,142,920,851.0018.5x-18.3x11.9x
Mon, 20 Mar 2023HK$405.8bHK$32.4b-HK$35,346,503,379.0022.9x-11.5x12.5x
Wed, 15 Feb 2023HK$440.1bHK$34.8b-HK$35,187,293,822.0031.4x-12.5x12.6x
Fri, 13 Jan 2023HK$444.2bHK$34.9b-HK$35,324,662,057.0028.7x-12.6x12.7x
Sun, 11 Dec 2022HK$393.0bHK$33.6b-HK$33,953,988,397.0024.6x-11.6x11.7x
Tue, 08 Nov 2022HK$364.0bHK$33.8b-HK$32,491,041,863.0018.5x-11.2x10.8x
Thu, 06 Oct 2022HK$298.5bHK$34.0b-HK$32,534,977,825.0019x-9.2x8.8x
Sat, 03 Sep 2022HK$332.7bHK$34.5b-HK$33,849,516,320.0015.6x-9.8x9.6x
Mon, 01 Aug 2022HK$328.6bHK$32.9b-HK$46,359,653,984.0013x-7.1x10x
Wed, 29 Jun 2022HK$387.5bHK$33.1b-HK$46,680,283,718.0015.3x-8.3x11.7x
Fri, 27 May 2022HK$321.4bHK$34.3b-HK$46,256,256,982.0012.8x-6.9x9.4x
Sun, 24 Apr 2022HK$331.6bHK$35.8b-HK$45,369,217,033.0012.9x-7.3x9.3x
Tue, 22 Mar 2022HK$325.4bHK$34.8b-HK$33,336,593,534.0013.3x-9.8x9.4x
Thu, 17 Feb 2022HK$311.6bHK$31.2b-HK$31,981,474,931.0012.6x-9.7x10x
Sat, 15 Jan 2022HK$379.3bHK$31.1b-HK$31,825,549,632.0013.3x-11.9x12.2x
Mon, 13 Dec 2021HK$480.7bHK$31.1b-HK$31,827,233,997.0013.5x-15.1x15.5x
Wed, 10 Nov 2021HK$447.8bHK$30.9b-HK$31,620,779,940.0013.8x-14.2x14.5x
Fri, 08 Oct 2021HK$497.1bHK$30.5b-HK$31,550,708,496.0015.3x-15.8x16.3x
Sun, 05 Sep 2021HK$529.2bHK$30.2b-HK$32,058,827,347.3517.5x-16.5x17.5x
Tue, 03 Aug 2021HK$569.8bHK$30.2b-HK$32,058,827,347.3513.4x-17.8x18.9x
Price to Earnings Ratio

-20.3x


Total Market Cap: HK$651.9bTotal Earnings: -HK$32,058,827,347.35Total Revenue: HK$30.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Hong Kong Biotech Industry Price to Earnings3Y Average -14.5x202220232024
Current Industry PE
  • Investors are pessimistic on the Hong Kong Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 11.1x is higher than the industry's current PS ratio of 6.7x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have improved over the last three years.
  • Revenues for these companies have grown 18% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Comparison

How does Hong Kong Biotech compare with similar industries?

HK Market0.61%
Healthcare-2.84%
Biotech-2.50%
Biotech-2.50%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6990 Sichuan Kelun-Biotech BiopharmaceuticalHK$172.805.9%
+HK$2.1b
n/aPS23.3x
2509 Qyuns TherapeuticsHK$28.3020.2%
+HK$1.1b
n/aPS396.3x
6855 Ascentage Pharma Group InternationalHK$24.807.6%
+HK$498.2m
32.9%PS29.6x
2480 Beijing Luzhu BiotechnologyHK$22.6011.9%
+HK$485.9m
-27.7%PB4.2x
9969 InnoCare PharmaHK$4.755.8%
+HK$457.8m
-26.4%PS10.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

1877

HK$11.28

Shanghai Junshi Biosciences

7D

-3.9%

1Y

-48.5%

2171

HK$5.54

CARsgen Therapeutics Holdings

7D

-10.1%

1Y

-44.2%

2179

HK$9.17

Jiangsu Recbio Technology

7D

1.3%

1Y

-32.7%

6990

HK$172.80

Sichuan Kelun-Biotech Biopharmaceutical

7D

5.9%

1Y

n/a

6660

HK$7.18

AIM Vaccine

7D

1.3%

1Y

-84.1%

2509

HK$28.30

Qyuns Therapeutics

7D

20.2%

1Y

n/a

2496

HK$8.36

Wuhan YZY Biopharma

7D

11.8%

1Y

n/a

2480

HK$22.60

Beijing Luzhu Biotechnology

7D

11.9%

1Y

-27.7%